A
Ashwin N. Ananthakrishnan
Researcher at Harvard University
Publications - 529
Citations - 30046
Ashwin N. Ananthakrishnan is an academic researcher from Harvard University. The author has contributed to research in topics: Inflammatory bowel disease & Ulcerative colitis. The author has an hindex of 70, co-authored 468 publications receiving 22807 citations. Previous affiliations of Ashwin N. Ananthakrishnan include Boston Children's Hospital & Indian Institute of Technology Madras.
Papers
More filters
Proceedings ArticleDOI
P100 Efficacy and safety of ozanimod in older patients with ulcerative colitis (UC): post hoc analysis of the True North study
Faisal Ismail Sheikh,Peter M. Irving,Ashwin N. Ananthakrishnan,Irina Blumenstein,Sara N. Horst,Harris A. Ahmad,Garrett Lawlor,Vanessa Hobbs,Anjali Jain,Arteid Memaj,Nuruzzaman Khan +10 more
TL;DR: In this paper , the efficacy and safety of ozanimod (OZA) in patients aged ≥ 60 years (y) with chronic inflammatory bowel disease (CBD) were evaluated.
Journal ArticleDOI
Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
Rahul S. Dalal,Ashwin N. Ananthakrishnan,Matthew J. Hamilton,Matthew J. Hamilton,Rachel W. Winter,Rachel W. Winter +5 more
Posted ContentDOI
Appropriate management of steroids and discharge planning during and after hospital admission for moderate-severe ulcerative colitis
Parambir S. Dulai,Vijay Gopal Rai,Laura E. Raffals,Dana J. Lukin,David Hudesman,Gursimran Kochhar,Oriana M. Damas,Jenny Sauk,A Levy,M. Anthony Sofia,Anne G. Tuskey,Parakkal Deepak,Andres Yarur,Anita Afzali,Ashwin N. Ananthakrishnan,Raymond K. Cross,Stephen B. Hanauer,Corey A. Siegel +17 more
TL;DR:
Journal ArticleDOI
Gut microbial metabolism of 5-asa is prospectively associated with treatment failure in patients with ibd
Raaj S. Mehta,Jared R. Mayers,Yancong Zhang,Amrisha Bhosle,Long Nguyen,Wenjie Ma,Ashwin N. Ananthakrishnan,Eric A. Franzosa,Emily P. Balskus,Andrew T. Chan,Curtis Huttenhower +10 more
TL;DR: In this article , the prospective association between gut microbial acetyltransferases with risk of 5-aminosalicylic acid (5-ASA) treatment failure in the ongoing "Study of a Prospective Adult Research Cohort with IBD" (SPARC IBD).
Journal ArticleDOI
Economic Burden Of Fatigue In Inflammatory Bowel Disease
Ashwin N. Ananthakrishnan,Raj Desai,Wan Ju Lee,Jennifer Griffith,Naijun Chen,Edward V. Loftus +5 more
TL;DR: In this paper , the real-world impact of fatigue on healthcare costs in patients newly diagnosed with inflammatory bowel disease (IBD) was assessed by collecting medical/pharmacy claims data on patients with IBD between 01/01/2000 and 03/31/2019 from the IBM® MarketScan® commercial claims database.